Chronic Fatigue Clinical Trials

• Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
  ClinicalTrials.gov Identifier: NCT00478465 - Active, not recruiting
  Chronic Fatigue Syndrome
  
• Autonomic Nervous System and Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00580619 - Recruiting
  Chronic Fatigue Syndrome; Orthostatic Intolerance; Postural Tachycardia
  
• Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00375973 - Recruiting
  Fatigue Syndrome, Chronic
  
• Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00433355 - Recruiting
  Chronic Fatigue Syndrome
  
• Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00498485 - Recruiting
  Chronic Fatigue Syndrome
  
• Study of Ampligen in Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00215813 - Recruiting
  Chronic Fatigue Syndrome
  
• Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00540254 - Recruiting
  Chronic Fatigue Syndrome; Behavioral Therapy Targeted to Sleep Problems
  
• Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00042848 - Active, not recruiting
  Fatigue; unspecified adult solid tumor, protocol specific
  
• Genetics of Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00071162 - Active, not recruiting
  Fibromyalgia; Irritable Bowel Syndrome; Chronic Fatigue Syndrome; Depression
  
• Cancer Related Fatigue in Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00261534 - Active, not recruiting
  Cancer; Fatigue
  
• Fatigue in Emergency Center Patients
  ClinicalTrials.gov Identifier: NCT00504985 - Active, not recruiting
  Advanced Cancer; Hematologic Malignancy; Fatigue
  
• Levocarnitine in Treating Fatigue in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00091169 - Active, not recruiting
  Fatigue; unspecified adult solid tumor, protocol specific
  
• Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00052221 - Active, not recruiting
  unspecified adult solid tumor, protocol specific; Fatigue
  
• American Ginseng in Treating Patients With Cancer-Related Fatigue
  ClinicalTrials.gov Identifier: NCT00182780 - Active, not recruiting
  Fatigue; unspecified adult solid tumor, protocol specific
  
• The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00215800 - Completed
  Chronic Fatigue Syndrome; Myalgic Encephalomyelitis
  
• Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096356 - Recruiting
  Breast Cancer; Fatigue
  
• Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients with Unresectable Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00040885 - Active, not recruiting
  Anorexia; Cachexia; Fatigue; Non-small cell lung cancer
  
• Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer
  ClinicalTrials.gov Identifier: NCT00178373 - Active, not recruiting
  Cancer; Fatigue; Chemotherapy
  
• Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
  ClinicalTrials.gov Identifier: NCT00052286 - Active, not recruiting
  adult brain tumor; Fatigue; cognitive/functional effects
  
• Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial
  ClinicalTrials.gov Identifier: NCT00200096 - Recruiting
  Cancer
  
• Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
  recurrent prostate cancer; Anemia; Fatigue
  
• Methylphenidate and a Nursing Telephone Intervention for Fatigue
  ClinicalTrials.gov Identifier: NCT00424099 - Recruiting
  Advanced Cancer; Fatigue
  
• Nutritional Assessment Intervention to Improve Cancer-Related Fatigue
  ClinicalTrials.gov Identifier: NCT00507260 - Recruiting
  Leukemia; Lymphoma; Fatigue
  
• Fatigue Intervention Trial for Breast Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00513136 - Recruiting
  Fatigue
  
• Post-TBI Fatigue and Its Treatment
  ClinicalTrials.gov Identifier: NCT00233090 - Recruiting
  Fatigue
  
• Sleep Disordered Breathing in Gulf War Syndrome Veterans and the Effect of Continuous Positive Airway Pressure (CPAP) Treatment
  ClinicalTrials.gov Identifier: NCT00252629 - Recruiting
  Gulf War Syndrome; Chronic Fatigue Syndrome; Functional Somatic Syndrome; Upper Airway Resistance Syndrome; Sleep Apnea
  
• Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
  ClinicalTrials.gov Identifier: NCT00004914 - Active, not recruiting
  Anemia; unspecified adult solid tumor, protocol specific; Fatigue
  
• Darbepoetin Alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00046982 - Active, not recruiting
  Fatigue; Anemia; unspecified adult solid tumor, protocol specific
  
• Modafinil in Treating Fatigue in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00112515 - Active, not recruiting
  Depression; cognitive/functional effects; Quality of Life; Fatigue; unspecified adult solid tumor, protocol specific
  
• Study of the Hypothalmic-Pituitary-Adrenal (HPA) Axis and its Role in Major Depression
  ClinicalTrials.gov Identifier: NCT00001479 - Completed
  Fatigue Syndrome, Chronic; Healthy; Mood Disorders
  
• A Computer-Based Intervention for Medically Unexplained Physical Symptoms
  ClinicalTrials.gov Identifier: NCT00468013 - Recruiting
  Fibromyalgia; Irritable Bowel Syndrome; Chronic Fatigue Syndrome
  
• Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy or Chronic Fatigue Syndrome in Patients With HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00552682 - Recruiting
  HIV Infections
  
• A Randomized Study of Polarity or Massage Therapy to Reduce Fatigue in Breast Cancer Patients During Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00288795 - Recruiting
  Fatigue
  
• Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy
  ClinicalTrials.gov Identifier: NCT00188331 - Recruiting
  Cognition; Fatigue; Colorectal Neoplasm
  
• Combined Strength Training and Functional Endurance Exercise Regimen on Cancer -Related Fatigue and Physical Performance
  ClinicalTrials.gov Identifier: NCT00421057 - Recruiting
  Breast Cancer; Fatigue
  
• Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00177840 - Not yet recruiting
  Fatigue
  
• Methylphenidate in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00003266 - Active, not recruiting
  unspecified adult solid tumor, protocol specific; Fatigue; Quality of Life
  
• Fatigue and Cancer Treatment(FACT)- an Exercise Intervention
  ClinicalTrials.gov Identifier: NCT00181129 - Recruiting
  Cancer,; Fatigue
  
• Modafinil for Fatigue in HIV/AIDS
  ClinicalTrials.gov Identifier: NCT00118378 - Recruiting
  HIV Infections; Fatigue
  
• BAY 43-9006 in Treating Patients With Imatinib Mesylate-Resistant Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00085007 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Postmenopausal Breast Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00526526 - Recruiting
  Breast Cancer; Depression; Fatigue; Pain
  
• Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00574145 - Recruiting
  Breast Cancer; Depression; Fatigue; Psychosocial Effects/Treatment
  
• Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002592 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00559195 - Recruiting
  Anemia; Fatigue; Unspecified Adult Solid Tumor, Protocol Specific
  
• Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00011934 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Valeriana Officinalis (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
  ClinicalTrials.gov Identifier: NCT00075842 - Active, not recruiting
  Sleep Disorders; unspecified adult solid tumor, protocol specific; Fatigue
  
• Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
  ClinicalTrials.gov Identifier: NCT00049465 - Active, not recruiting
  Cancer; Depression; Fatigue; menopausal symptoms; psychosocial effects and treatment; transitional care planning
  
• Methylphenidate in Treating Patients With Fatigue Caused by Cancer
  ClinicalTrials.gov Identifier: NCT00376675 - Not yet recruiting
  Fatigue; Unspecified Adult Solid Tumor, Protocol Specific
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00005948 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia
  
• Infliximab in Treating Fatigue in Postmenopausal Women Who Have Undergone Treatment for Stage 0, Stage I, or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00112749 - Recruiting
  stage I breast cancer; stage II breast cancer; breast cancer in situ; Fatigue
  
• Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003239 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002674 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00335491 - Recruiting
  Bladder Cancer; Breast Cancer; Colorectal Cancer; Esophageal Cancer; Fatigue; Lung Cancer; Lymphoma; Ovarian Cancer; Prostate Cancer
  
• High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002788 - Active, not recruiting
  stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
  
• Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
  ClinicalTrials.gov Identifier: NCT00004912 - Active, not recruiting
  Cachexia; unspecified adult solid tumor, protocol specific; Fatigue
  
• BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00112801 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004218 - Active, not recruiting
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Use of Armodafinil for Fatigue in Sarcoidosis
  ClinicalTrials.gov Identifier: NCT00555347 - Recruiting
  Sarcoidosis; Fatigue; Sleepiness
  
• Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002789 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003829 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
  
• Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue
  ClinicalTrials.gov Identifier: NCT00518869 - Recruiting
  Quality of Life; Fatigue; Complementary
  
• Efficacy, Safety and Long-Term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)
  ClinicalTrials.gov Identifier: NCT00237120 - Active, not recruiting
  Chronic Myelogenous Leukemia in Chronic Phase
  
• BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00064233 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Glucocorticoid Effects on Cellular Cytokine Release
  ClinicalTrials.gov Identifier: NCT00001415 - Completed
  Depressive Disorder; Fatigue Syndrome, Chronic; Fibromyalgia; Healthy; Inflammation
  
• Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00004052 - Active, not recruiting
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00072007 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
  chronic phase chronic myelogenous leukemia
  
• Sleep Architecture and Chemotherapy-Related Fatigue
  ClinicalTrials.gov Identifier: NCT00178204 - Recruiting
  Fatigue; Sleep; Chemotherapy; Cancer
  
• Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase
  ClinicalTrials.gov Identifier: NCT00003694 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Fludarabine Followed by Campath-1H in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004857 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
  
• Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002778 - Active, not recruiting
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
  
• Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00037024 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage I prostate cancer; stage II prostate cancer; Fatigue; Nutrition; psychosocial effects/treatment; ...
  
• PH III Chronic CML - Follow On
  ClinicalTrials.gov Identifier: NCT00123474 - Active, not recruiting
  Chronic Phase Chronic Myelogenous Leukemia
  
• Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00030303 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Oblimersen Plus Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00049192 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• Efficacy of 400 Mg Vs. 800 Mg Gleevec® in Chronic Myeloid Leukemia in Chronic Phase Patients Using Molecular Endpoints
  ClinicalTrials.gov Identifier: NCT00124748 - Active, not recruiting
  Chronic myeloid leukemia (CML) in chronic phase
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002838 - Active, not recruiting
  stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia
  
• Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003248 - Active, not recruiting
  stage II chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia; stage IV chronic lymphocytic leukemia; ...
  
• BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00112775 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• Interferon alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002869 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon alfa
  ClinicalTrials.gov Identifier: NCT00004933 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia
  
• Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003727 - Active, not recruiting
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003764 - Active, not recruiting
  stage 0 chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002761 - Active, not recruiting
  relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Fludarabine and Rituximab Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00098670 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients
  ClinicalTrials.gov Identifier: NCT00088140 - Active, not recruiting
  Hepatitis C, Chronic
  
• Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00336089 - Recruiting
  Breast Cancer; Fatigue; Pain
  
• Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00028847 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) with Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
  ClinicalTrials.gov Identifier: NCT00038649 - Active, not recruiting
  Myelogenous Leukemia, Chronic, Chronic Phase
  
• Interferon alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003561 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Interferon alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00045422 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
  
• Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005850 - Active, not recruiting
  Anxiety Disorder; Depression; Fatigue; Non-small cell lung cancer
  
• Armodafinil for Fibromyalgia Fatigue
  ClinicalTrials.gov Identifier: NCT00568919 - Recruiting
  Fibromyalgia; Fatigue
  
• Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00049075 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Fludarabine and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00119340 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
  
• 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
  ClinicalTrials.gov Identifier: NCT00225537 - Active, not recruiting
  Chronic Hepatitis C; Chronic Hepatitis B
  
• Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00006226 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Peg-Ifn Dose Evaluations for Previously Untreated Subjects with Chronic Hepatitis C Infected with Genotype 1
  ClinicalTrials.gov Identifier: NCT00081770 - Active, not recruiting
  Chronic Hepatitis C
  
• Hyporeactivity and Gulf War Illness
  ClinicalTrials.gov Identifier: NCT00100412 - Completed
  Gulf War Syndrome; Chronic Fatigue Syndrome; Post-Traumatic Stress Disorder
  
• Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00017108 - Active, not recruiting
  stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia